MOTS — Motus GI Holdings Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$2.64m
- $0.32m
Motus GI Holdings Inc expected to post a loss of 95 cents a share - Earnings Preview
Brief: Motus GI Announces Executive Leadership Restructuring And Additional Cost Saving Initiatives To Support Near-Term Milestones
Brief: Motus Gi Holdings- On March 31, Got Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Brief: Motus GI Reports Q4 Results
Motus GI Holdings Inc reports results for the quarter ended in December - Earnings Summary
Motus GI Holdings Inc expected to post a loss of $1.17 a share - Earnings Preview
Brief: Motus Gi Holdings Inc Says On January 4, 2023 Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Motus GI Holdings Announces Exploration Of Strategic Alternatives
Brief: Motus Gi Announces Improvement Of Pure-Vu® Evs System For Use In Upper Gastrointestinal (Gi) Bleeding Procedures Following Successful Pre-Clinical Tests
U.S. RESEARCH ROUNDUP-Calithera Biosciences, Haynes International, Lumos Pharma
Motus GI Holdings Inc reports results for the quarter ended in September - Earnings Summary
Brief: Motus GI Reports Third Quarter 2022 Financial Results
Motus GI Holdings Inc expected to post a loss of $1.88 a share - Earnings Preview
Brief: Motus Gi To Release Q3 Results On November 14
U.S. STOCKS ON THE MOVE-Starbucks, Tesla, Wynn Resorts
Brief: Motus GI Announces Positive Clinical Data For Pure-Vu EVS In Three Poster Presentations
Brief: Motus Gi Named A Sole Source Supplier With U.S. Department Of Veteran Affairs
U.S. RESEARCH ROUNDUP-Goodrx Holdings, Nextnav, Olo
Brief: Motus Gi Reports Second Quarter 2022 Financial Results And Provides Business Update